160 related articles for article (PubMed ID: 37631318)
41. Carboplatin loaded Surface modified PLGA nanoparticles: Optimization, characterization, and in vivo brain targeting studies.
Jose S; Juna BC; Cinu TA; Jyoti H; Aleykutty NA
Colloids Surf B Biointerfaces; 2016 Jun; 142():307-314. PubMed ID: 26970818
[TBL] [Abstract][Full Text] [Related]
42. Preparation, characterization, and in vivo study of rhein-loaded poly(lactic-co-glycolic acid) nanoparticles for oral delivery.
Yuan Z; Gu X
Drug Des Devel Ther; 2015; 9():2301-9. PubMed ID: 25960633
[TBL] [Abstract][Full Text] [Related]
43. QbD enabled optimization of solvent shifting method for fabrication of PLGA-based nanoparticles for promising delivery of Capecitabine for antitumor activity.
Jena GK; Patra CN; Panigrahi KC; Sruti J; Patra P; Parhi R
Drug Deliv Transl Res; 2022 Jun; 12(6):1521-1539. PubMed ID: 34505271
[TBL] [Abstract][Full Text] [Related]
44. Preparation and characterization of teniposide PLGA nanoparticles and their uptake in human glioblastoma U87MG cells.
Mo L; Hou L; Guo D; Xiao X; Mao P; Yang X
Int J Pharm; 2012 Oct; 436(1-2):815-24. PubMed ID: 22846410
[TBL] [Abstract][Full Text] [Related]
45. Antimicrobial activity of a new synthetic peptide loaded in polylactic acid or poly(lactic-co-glycolic) acid nanoparticles against Pseudomonas aeruginosa, Escherichia coli O157:H7 and methicillin resistant Staphylococcus aureus (MRSA).
Cruz J; Flórez J; Torres R; Urquiza M; Gutiérrez JA; Guzmán F; Ortiz CC
Nanotechnology; 2017 Mar; 28(13):135102. PubMed ID: 28266350
[TBL] [Abstract][Full Text] [Related]
46. Temozolomide hexadecyl ester targeted plga nanoparticles for drug-resistant glioblastoma therapy via intranasal administration.
Wang S; Yu Y; Wang A; Duan X; Sun Y; Wang L; Chu L; Lv Y; Cui N; Fan X; Sha C; Xu L; Sun K
Front Pharmacol; 2022; 13():965789. PubMed ID: 36059989
[No Abstract] [Full Text] [Related]
47. Polymeric nanoencapsulation of zaleplon into PLGA nanoparticles for enhanced pharmacokinetics and pharmacological activity.
Haggag YA; Abosalha AK; Tambuwala MM; Osman EY; El-Gizawy SA; Essa EA; Donia AA
Biopharm Drug Dispos; 2021 Jan; 42(1):12-23. PubMed ID: 33320969
[TBL] [Abstract][Full Text] [Related]
48. Hyaluronic acid-decorated poly(lactic-co-glycolic acid) nanoparticles for combined delivery of docetaxel and tanespimycin.
Pradhan R; Ramasamy T; Choi JY; Kim JH; Poudel BK; Tak JW; Nukolova N; Choi HG; Yong CS; Kim JO
Carbohydr Polym; 2015 Jun; 123():313-23. PubMed ID: 25843864
[TBL] [Abstract][Full Text] [Related]
49. Development and optimisation of 3-Acetyl-11-keto-β-boswellic acid loaded poly-lactic-co-glycolic acid-nanoparticles with enhanced oral bioavailability and in-vivo anti-inflammatory activity in rats.
Bairwa K; Jachak SM
J Pharm Pharmacol; 2015 Sep; 67(9):1188-97. PubMed ID: 25851251
[TBL] [Abstract][Full Text] [Related]
50. Enhancing ovarian cancer conventional chemotherapy through the combination with cannabidiol loaded microparticles.
Fraguas-Sánchez AI; Fernández-Carballido A; Delie F; Cohen M; Martin-Sabroso C; Mezzanzanica D; Figini M; Satta A; Torres-Suárez AI
Eur J Pharm Biopharm; 2020 Sep; 154():246-258. PubMed ID: 32682943
[TBL] [Abstract][Full Text] [Related]
51. Investigation of imatinib loaded surface decorated biodegradable nanocarriers against glioblastoma cell lines: Intracellular uptake and cytotoxicity studies.
Khan AM; Ahmad FJ; Panda AK; Talegaonkar S
Int J Pharm; 2016 Jun; 507(1-2):61-71. PubMed ID: 27154254
[TBL] [Abstract][Full Text] [Related]
52. Development of cannabidiol nanoemulsion for direct nose to brain delivery: statistical optimization,
Ahmed B; Rizwanullah M; Mir SR; Akhtar MS; Amin S
Biomed Mater; 2022 Sep; 17(6):. PubMed ID: 36108625
[TBL] [Abstract][Full Text] [Related]
53. [Rapamycin-loaded poly (lactic-co-glycolic) acid nanoparticles for intraarterial local drug delivery: preparation, characterization, and in vitro/in vivo release].
Miao LF; Yang J; Huang CL; Song CX; Zeng YJ; Chen LF; Zhu WL
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Aug; 30(4):491-7. PubMed ID: 18795627
[TBL] [Abstract][Full Text] [Related]
54. Building and behavior of a pH-stimuli responsive chitosan nanoparticles loaded with folic acid conjugated gemcitabine silver colloids in MDA-MB-453 metastatic breast cancer cell line and pharmacokinetics in rats.
Karuppaiah A; Babu D; Selvaraj D; Natrajan T; Rajan R; Gautam M; Ranganathan H; Siram K; Nesamony J; Sankar V
Eur J Pharm Sci; 2021 Oct; 165():105938. PubMed ID: 34256103
[TBL] [Abstract][Full Text] [Related]
55. In vitro evaluation of 5-aminolevulinic acid (ALA) loaded PLGA nanoparticles.
Shi L; Wang X; Zhao F; Luan H; Tu Q; Huang Z; Wang H; Wang H
Int J Nanomedicine; 2013; 8():2669-76. PubMed ID: 23926429
[TBL] [Abstract][Full Text] [Related]
56. Sonication tailored enhance cytotoxicity of naringenin nanoparticle in pancreatic cancer: design, optimization, and
Akhter MH; Kumar S; Nomani S
Drug Dev Ind Pharm; 2020 Apr; 46(4):659-672. PubMed ID: 32208984
[No Abstract] [Full Text] [Related]
57. Preparation, characterization, and safety evaluation of poly(lactide-co-glycolide) nanoparticles for protein delivery into macrophages.
Guedj AS; Kell AJ; Barnes M; Stals S; Gonçalves D; Girard D; Lavigne C
Int J Nanomedicine; 2015; 10():5965-79. PubMed ID: 26445538
[TBL] [Abstract][Full Text] [Related]
58. Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer's disease.
Meng Q; Wang A; Hua H; Jiang Y; Wang Y; Mu H; Wu Z; Sun K
Int J Nanomedicine; 2018; 13():705-718. PubMed ID: 29440896
[TBL] [Abstract][Full Text] [Related]
59. Improved efficacy of cisplatin in combination with a nano-formulation of pentacyclic triterpenediol.
Alam N; Qayum A; Kumar A; Khare V; Sharma PR; Andotra SS; Singh SK; Koul S; Gupta PN
Mater Sci Eng C Mater Biol Appl; 2016 Nov; 68():109-116. PubMed ID: 27524002
[TBL] [Abstract][Full Text] [Related]
60. Fabrication of long-acting insulin formulation based on poly (3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) nanoparticles: preparation, optimization, characterization, and in vitro evaluation.
Bayrami S; Esmaili Z; SeyedAlinaghi S; Jamali Moghadam SR; Bayrami S; Akbari Javar H; Rafiee Tehrani M; Dorkoosh FA
Pharm Dev Technol; 2019 Feb; 24(2):176-188. PubMed ID: 29557733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
